Form 8-K - Current report:
SEC Accession No. 0001193125-24-174318
Filing Date
2024-07-02
Accepted
2024-07-02 16:05:55
Documents
15
Period of Report
2024-06-26
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d799103d8k.htm   iXBRL 8-K 33588
2 EX-10.1 d799103dex101.htm EX-10.1 230310
6 GRAPHIC g799103g0702111704948.jpg GRAPHIC 2751
  Complete submission text file 0001193125-24-174318.txt   453434

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA vera-20240626.xsd EX-101.SCH 2835
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE vera-20240626_lab.xml EX-101.LAB 18737
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE vera-20240626_pre.xml EX-101.PRE 11697
17 EXTRACTED XBRL INSTANCE DOCUMENT d799103d8k_htm.xml XML 3783
Mailing Address 8000 MARINA BOULEVARD, SUITE 120 BRISBANE CA 94005
Business Address 8000 MARINA BOULEVARD, SUITE 120 BRISBANE CA 94005 650-770-0077
Vera Therapeutics, Inc. (Filer) CIK: 0001831828 (see all company filings)

EIN.: 812744449 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40407 | Film No.: 241095137
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)